Eton Pharmaceuticals, Inc. announced that it has appointed Jenn Adams to its board of directors effective March 17, 2021. Ms. Adams brings extensive commercial, operational, and leadership experience in the pharmaceutical industry. Ms. Adams’ experience includes leading and growing both Fortune 500 public and private equity-backed companies. She currently serves as CEO of August Bioservices. Prior to joining August Bioservices, she served as SVP & President of AmerisourceBergen’s Clinical Product Solutions Business Unit. Ms. Adams spent her early career at Baxter Healthcare, serving in leadership roles in its Medication Delivery and Fenwal businesses. Ms. Adams also serves as a Senior Advisor to Oak HC/FT. Ms. Adams serves on the nonprofit Board of LifeScience Tennessee. Ms. Adams replaces Mark Baum, who stepped down from the board effective March 17 in order to devote more time to Harrow Health Inc., where he serves as Chief Executive Officer.